Name | D-(+)-Ribonic Acid γ-Lactone |
---|---|
Synonyms |
D(+)-Ribonic acid gamma-lactone
D-Ribono-1,4-lactone 3,4-Dihydroxy-5-(hydroxymethyl)dihydro-2(3H)-furanone 3,4-dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one (non-preferred name) MFCD00063241 .γ.-Lactone of ribonic acid D-(+)-Ribonic γ-lactone EINECS 226-256-5 D-(+)-Ribono-1,4-lactone |
Description | D-Ribonolactone is sugar lactone and an inhibitor of β-galactosidase of Escherichia coli with a Ki of 26 mM[1]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | Ki: 26 mM (β-galactosidase) |
References |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 364.3±11.0 °C at 760 mmHg |
Melting Point | 83-85ºC |
Molecular Formula | C5H8O5 |
Molecular Weight | 148.114 |
Flash Point | 162.8±12.8 °C |
Exact Mass | 148.037170 |
PSA | 86.99000 |
LogP | -2.47 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.581 |
Safety Phrases | S22-S24/25 |
---|---|
WGK Germany | 3 |
HS Code | 2932209090 |
~66% 5336-08-3 |
Literature: BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; Location in patent: Page/Page column 93 ; |
~10% 5336-08-3 |
Literature: Isaac, Isabelle; Stasik, Imane; Beaupere, Daniel; Uzan, Raoul Tetrahedron Letters, 1995 , vol. 36, # 3 p. 383 - 386 |
~10% 5336-08-3 |
Literature: Procopio, Antonio; Gaspari, Marco; Nardi, Monica; Oliverio, Manuela; Tagarelli, Antonio; Sindona, Giovanni Tetrahedron Letters, 2007 , vol. 48, # 49 p. 8623 - 8627 |
~% 5336-08-3 |
Literature: Carbohydrate Research, , vol. 220, # 1 p. 117 - 126 |
~97% 5336-08-3 |
Literature: Pharmaceutical Chemistry Journal, , vol. 16, # 2 p. 135 - 139 Khimiko-Farmatsevticheskii Zhurnal, , vol. 16, # 2 p. 196 - 201 |
Precursor 3 | |
---|---|
DownStream 10 | |
HS Code | 2932209090 |
---|---|
Summary | 2932209090. other lactones. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |